AQR Capital Management’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.4M Sell
142,163
-34,620
-20% -$827K ﹤0.01% 1482
2025
Q1
$4.39M Sell
176,783
-111,716
-39% -$2.78M ﹤0.01% 1188
2024
Q4
$5.44M Sell
288,499
-257,709
-47% -$4.86M 0.01% 1063
2024
Q3
$8.22M Buy
546,208
+478,595
+708% +$7.2M 0.01% 864
2024
Q2
$1.93M Buy
67,613
+5,918
+10% +$169K ﹤0.01% 1460
2024
Q1
$1.8M Sell
61,695
-81,079
-57% -$2.37M ﹤0.01% 1462
2023
Q4
$4.82M Buy
142,774
+33,953
+31% +$1.15M 0.01% 966
2023
Q3
$3.34M Buy
108,821
+68,061
+167% +$2.09M 0.01% 1094
2023
Q2
$1.63M Buy
40,760
+11,696
+40% +$469K ﹤0.01% 1346
2023
Q1
$1.19M Buy
+29,064
New +$1.19M ﹤0.01% 1481
2021
Q2
Sell
-7,867
Closed -$551K 2278
2021
Q1
$551K Sell
7,867
-7,877
-50% -$552K ﹤0.01% 1795
2020
Q4
$942K Sell
15,744
-2,975
-16% -$178K ﹤0.01% 1536
2020
Q3
$1.13M Sell
18,719
-31,197
-62% -$1.87M ﹤0.01% 1358
2020
Q2
$2.62M Sell
49,916
-3,295
-6% -$173K ﹤0.01% 1039
2020
Q1
$1.78M Buy
53,211
+23,685
+80% +$794K ﹤0.01% 1110
2019
Q4
$1.34M Sell
29,526
-91,263
-76% -$4.14M ﹤0.01% 1421
2019
Q3
$4.6M Sell
120,789
-16,652
-12% -$634K 0.01% 991
2019
Q2
$5.98M Sell
137,441
-13,771
-9% -$599K 0.01% 918
2019
Q1
$5.76M Buy
151,212
+73,862
+95% +$2.81M 0.01% 941
2018
Q4
$3.33M Buy
77,350
+72,259
+1,419% +$3.11M ﹤0.01% 1073
2018
Q3
$250K Sell
5,091
-20,143
-80% -$989K ﹤0.01% 2152
2018
Q2
$809K Sell
25,234
-64,594
-72% -$2.07M ﹤0.01% 1803
2018
Q1
$2.8M Buy
+89,828
New +$2.8M ﹤0.01% 1216
2015
Q3
Sell
-10,703
Closed -$757K 2243
2015
Q2
$757K Sell
10,703
-818
-7% -$57.9K ﹤0.01% 1632
2015
Q1
$1.02M Sell
11,521
-5,886
-34% -$523K ﹤0.01% 1407
2014
Q4
$1.54M Sell
17,407
-41,994
-71% -$3.72M ﹤0.01% 1421
2014
Q3
$5.76M Buy
59,401
+44,900
+310% +$4.35M 0.02% 770
2014
Q2
$1.33M Sell
14,501
-2,400
-14% -$220K ﹤0.01% 1497
2014
Q1
$1.18M Sell
16,901
-18,900
-53% -$1.32M ﹤0.01% 1615
2013
Q4
$2.06M Sell
35,801
-2,506
-7% -$144K 0.01% 1343
2013
Q3
$1.84M Sell
38,307
-3,708
-9% -$178K 0.01% 1335
2013
Q2
$1.22M Buy
+42,015
New +$1.22M ﹤0.01% 1470